Karius Genomics Infectious Disease Diagnostic Ventures Announces Studies

As reported in Business Insider, Karius is transforming infectious disease diagnostics with genomics. At this year’s IDWeek Conference for Infectious Disease Clinicians, they announced the results of several critical studies.  Centered on the use of the Karius Test as a liquid biopsy for infectious diseases were the focus of the presentations. Research sites involved included:

  • St. Jude Children’s Research Hospital
  • Duke University
  • New York-Presbyterian Weill Cornell Medical Center
  • Florida Hospital Orlando
  • Ann & Robert H Lurie Children’s Hospital of Chicago
  • Stanford University
  • Children’s National Medical Center
  • The University of Florida

San Francisco-based Karius was founded in 2014. With a mission of conquering infectious diseases using genomics to analyze microbial cell-free DNA, the venture has raised $55 million in just 4 years. Owler estimates revenue at $2.5 million and approximately 35 employees.  An analysis on LinkedIn makes the employee count more around 65.  TrialSite News research estimates the venture’s cost is at least $10 to $15 million per year.

Responses